Identification of antiviral antihistamines for COVID-19 repurposing (Q104289159)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33309272%20AND%20SRC:MED&resulttype=core&format=json

19 December 2020

title

Identification of antiviral antihistamines for COVID-19 repurposing (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33309272%20AND%20SRC:MED&resulttype=core&format=json

19 December 2020

1 reference

1 reference

1 reference

inferred from abstract

8

Atul J Butte

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33309272%20AND%20SRC:MED&resulttype=core&format=json

19 December 2020

1

Leah R Reznikov

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33309272%20AND%20SRC:MED&resulttype=core&format=json

19 December 2020

author name string

Michael H Norris

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33309272%20AND%20SRC:MED&resulttype=core&format=json

19 December 2020

Rohit Vashisht

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33309272%20AND%20SRC:MED&resulttype=core&format=json

19 December 2020

Andrew P Bluhm

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33309272%20AND%20SRC:MED&resulttype=core&format=json

19 December 2020

Danmeng Li

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33309272%20AND%20SRC:MED&resulttype=core&format=json

19 December 2020

Yan-Shin J Liao

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33309272%20AND%20SRC:MED&resulttype=core&format=json

19 December 2020

Ashley Brown

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33309272%20AND%20SRC:MED&resulttype=core&format=json

19 December 2020

David A Ostrov

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33309272%20AND%20SRC:MED&resulttype=core&format=json

19 December 2020

publication date

3 December 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33309272%20AND%20SRC:MED&resulttype=core&format=json

Biochemical and Biophysical Research Communications

19 December 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33309272%20AND%20SRC:MED&resulttype=core&format=json

Delivering Benefits at Speed Through Real-World Repurposing of Off-Patent Drugs: The COVID-19 Pandemic as a Case in Point

19 December 2020

volume

538

0 references

page(s)

173-179

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

Chloroquine is a potent inhibitor of SARS coronavirus infection and spread

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

The Use of Antimalarial Drugs against Viral Infection

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

Structure-based discovery of a novel angiotensin-converting enzyme 2 inhibitor

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents.

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

Prediction of off-target effects on angiotensin-converting enzyme 2.

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

Tackling SARS-CoV-2: proposed targets and repurposed drugs

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

Famotidine Use is Associated with Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

Crystal structure of the human σ1 receptor

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

Acid exposure disrupts mucus secretion and impairs mucociliary transport in neonatal piglet airways

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

Coronavirus NSP6 restricts autophagosome expansion

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

Sensitive Assay for determination of Hydroxyzine in Plasma and its Human Pharmacokinetics

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

Pharmacokinetics of diphenhydramine and a demethylated metabolite following intravenous and oral administration.

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal spray

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

The impact of asthma on mortality in COVID-19 patients

8 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.BBRC.2020.11.095

10.1016/J.BBRC.2020.11.095

8 June 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33309272%20AND%20SRC:MED&resulttype=core&format=json

19 December 2020

0 references

1 reference